首页> 外文期刊>Journal of Chemistry >Simultaneous HPTLC Estimation of Simvastatin and Ezetimibe in Tablet Dosage Form
【24h】

Simultaneous HPTLC Estimation of Simvastatin and Ezetimibe in Tablet Dosage Form

机译:同时HPTLC估计辛伐他汀和欧替米贝在片剂剂型中

获取原文
           

摘要

A method enabling the precise and quick simultaneous analysis of simvastatin and ezetimibe in tablet formulation by high performance thin layer chromatography has been presented. Samples of simvastatin and ezetimibe in organic solvents were separated on a plate coated with silica gel 60 F-254 and the chromatograms were developed using a mixture of chloroform and methanol (9.5: 0.5 %v/v). The method has a linearity range of 40-280 ng.mL-1for both the drugs when scanned at 254 nm. The limit of detection and limit of quantitation was found to be 30 and 100 ng.band-1respectively, for both the drugs. The mean percent recovery was found to be 100.65 and 101.55 for simvastatin and ezetimibe. The intra-day and inter-day precision studies were carried out with mean RSD of 0.88 and 1.27 for ezetimibe and 1.35 and 1.50 for simvastatin.
机译:已经介绍了一种方法,其通过高性能薄层色谱法提出了通过高性能薄层色谱法在片剂配方中进行精确快速地分析辛伐他汀和ezetimibe。在涂有硅胶60f-254的板上分离有机溶剂中的辛伐他汀和ezetimibe的样品,并且使用氯仿和甲醇的混合物(9.5:0.5%v / v)进行色谱图。该方法的线性范围为40-280ng.ml-1,在254nm处扫描时两种药物。对于药物,发现检测极限和定量限制为30和100ng.Band-1。辛伐他汀和欧塞蒂米贝的平均百分比恢复是100.65和101.55。为辛伐他汀的ezetimibe和1.35和1.50的平均RSD进行了日内和日常的精确研究,为0.88和1.27。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号